{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T06:28:42Z","timestamp":1773296922359,"version":"3.50.1"},"reference-count":20,"publisher":"American Association for the Advancement of Science (AAAS)","issue":"4424","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Science"],"published-print":{"date-parts":[[1979,12,14]]},"abstract":"<jats:p>Caffeine (1,3,7-trimethylxanthine) is a biotransformation product of theophylline (1,3-dimethylxanthine) in the human fetus. Liver explants, obtained from human fetuses with gestational ages of 12 to 20 weeks, were incubated with theophylline and produced caffeine and, in lesser amounts, 1,3-dimethyluric acid and 3-methylxanthine. These findings suggest that the predominant pathway in theophylline metabolism in the fetus and newborn infant is the methylation reaction producing caffeine. This may contribute to the neonate's exceedingly slower elimination of caffeine relative to theophylline. Caffeine produced from theophylline may add to the pharmacologic effects of theophylline in newborn infants with apnea.<\/jats:p>","DOI":"10.1126\/science.515734","type":"journal-article","created":{"date-parts":[[2006,10,5]],"date-time":"2006-10-05T16:39:42Z","timestamp":1160066382000},"page":"1319-1321","source":"Crossref","is-referenced-by-count":46,"title":["Metabolism of Theophylline to Caffeine in Human Fetal Liver"],"prefix":"10.1126","volume":"206","author":[{"given":"Jacob V.","family":"Aranda","sequence":"first","affiliation":[{"name":"Developmental Pharmacology and Perinatal Research Unit, McGill University-Montreal Children's Hospital Research Institute, Montreal, Quebec H3H 1P3, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. Tom","family":"Louridas","sequence":"additional","affiliation":[{"name":"Developmental Pharmacology and Perinatal Research Unit, McGill University-Montreal Children's Hospital Research Institute, Montreal, Quebec H3H 1P3, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benedetto B.","family":"Vitullo","sequence":"additional","affiliation":[{"name":"Developmental Pharmacology and Perinatal Research Unit, McGill University-Montreal Children's Hospital Research Institute, Montreal, Quebec H3H 1P3, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philip","family":"Thom","sequence":"additional","affiliation":[{"name":"Developmental Pharmacology and Perinatal Research Unit, McGill University-Montreal Children's Hospital Research Institute, Montreal, Quebec H3H 1P3, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew","family":"Aldridge","sequence":"additional","affiliation":[{"name":"Developmental Pharmacology and Perinatal Research Unit, McGill University-Montreal Children's Hospital Research Institute, Montreal, Quebec H3H 1P3, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard","family":"Haber","sequence":"additional","affiliation":[{"name":"Developmental Pharmacology and Perinatal Research Unit, McGill University-Montreal Children's Hospital Research Institute, Montreal, Quebec H3H 1P3, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"221","reference":[{"key":"e_1_2_1_1_1","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1002\/cpt1979254447","volume":"25","year":"1979","unstructured":"ALDRIDGE, A, CAFFEINE METABOLISM IN THE NEWBORN, CLINICAL PHARMACOLOGY & THERAPEUTICS 25: 447 (1979).","journal-title":"CLINICAL PHARMACOLOGY & THERAPEUTICS"},{"key":"e_1_2_1_2_1","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0095-5108(18)31165-5","volume":"6","year":"1979","unstructured":"ARANDA, J.V., METHYLXANTHINES IN APNEA OF PREMATURITY, CLINICS IN PERINATOLOGY 6: 87 (1979).","journal-title":"CLINICS IN PERINATOLOGY"},{"key":"e_1_2_1_3_1","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/S0022-3476(79)80047-5","volume":"94","year":"1979","unstructured":"ARANDA, J.V., PHARMACOKINETIC PROFILE OF CAFFEINE IN THE PREMATURE NEWBORN-INFANT WITH APNEA, JOURNAL OF PEDIATRICS 94: 663 (1979).","journal-title":"JOURNAL OF PEDIATRICS"},{"key":"e_1_2_1_4_1","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/S0022-3476(74)80465-8","volume":"85","year":"1974","unstructured":"ARANDA, J.V., HEPATIC MICROSOMAL DRUG OXIDATION AND ELECTRON-TRANSPORT IN NEWBORN-INFANTS, JOURNAL OF PEDIATRICS 85: 534 (1974).","journal-title":"JOURNAL OF PEDIATRICS"},{"key":"e_1_2_1_5_1","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1056\/NEJM197608192950803","volume":"295","year":"1976","unstructured":"ARANDA, J.V., PHARMACOKINETIC ASPECTS OF THEOPHYLLINE IN PREMATURE NEWBORNS, NEW ENGLAND JOURNAL OF MEDICINE 295: 413 (1976).","journal-title":"NEW ENGLAND JOURNAL OF MEDICINE"},{"key":"e_1_2_1_6_1","unstructured":"ARANDA J.V. UNPUBLISHED."},{"key":"e_1_2_1_7_1","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1016\/S0022-3476(79)80246-2","volume":"94","year":"1979","unstructured":"BORY, C, METABOLISM OF THEOPHYLLINE TO CAFFEINE IN PREMATURE NEWBORN-INFANTS, JOURNAL OF PEDIATRICS 94: 988 (1979).","journal-title":"JOURNAL OF PEDIATRICS"},{"key":"e_1_2_1_8_1","first-page":"1204","volume":"2","year":"1978","unstructured":"BORY, C, BIOTRANSFORMATION OF THEOPHYLLINE TO CAFFEINE IN PREMATURE NEWBORN, LANCET 2: 1204 (1978).","journal-title":"LANCET"},{"key":"e_1_2_1_9_1","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S0021-9258(18)70714-X","volume":"228","year":"1957","unstructured":"CORNISH, H.H., A STUDY OF THE METABOLISM OF THEOBROMINE, THEOPHYLLINE, AND CAFFEINE IN MAN, JOURNAL OF BIOLOGICAL CHEMISTRY 228: 315 (1957).","journal-title":"JOURNAL OF BIOLOGICAL CHEMISTRY"},{"key":"e_1_2_1_10_1","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1203\/00006450-197305000-00006","volume":"7","year":"1973","unstructured":"GAULL, G.E., DEVELOPMENT OF METHYLTRANSFERASE ACTIVITIES OF HUMAN FETAL TISSUES, PEDIATRIC RESEARCH 7: 527 (1973).","journal-title":"PEDIATRIC RESEARCH"},{"key":"e_1_2_1_11_1","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1203\/00006450-197202000-00002","volume":"6","year":"1972","unstructured":"GLUCK, L, BIOCHEMICAL DEVELOPMENT OF SURFACE-ACTIVITY IN MAMMALIAN LUNG .4. PULMONARY LECITHIN SYNTHESIS IN HUMAN FETUS AND NEWBORN AND ETIOLOGY OF RESPIRATORY DISTRESS SYNDROME, PEDIATRIC RESEARCH 6: 81 (1972).","journal-title":"PEDIATRIC RESEARCH"},{"key":"e_1_2_1_12_1","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1016\/0016-5085(78)90695-9","volume":"74","year":"1978","unstructured":"HABER, L.R., BILE-ACID CONJUGATION IN ORGAN-CULTURE OF HUMAN FETAL LIVER, GASTROENTEROLOGY 74: 1214 (1978).","journal-title":"GASTROENTEROLOGY"},{"key":"e_1_2_1_13_1","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/0024-3205(75)90343-4","volume":"16","year":"1975","unstructured":"HORNING, M.G., DRUG-METABOLISM IN HUMAN NEONATE, LIFE SCIENCES 16: 651 (1975).","journal-title":"LIFE SCIENCES"},{"key":"e_1_2_1_14_1","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1002\/cpt1976193375","volume":"19","year":"1976","unstructured":"JENNE, J.W., RELATIONSHIP OF URINARY METABOLITES OF THEOPHYLLINE TO SERUM THEOPHYLLINE LEVELS, CLINICAL PHARMACOLOGY & THERAPEUTICS 19: 375 (1976).","journal-title":"CLINICAL PHARMACOLOGY & THERAPEUTICS"},{"key":"e_1_2_1_15_1","first-page":"213","volume":"196","year":"1976","unstructured":"LOHMANN, S.M., THEOPHYLLINE METABOLISM BY RAT-LIVER MICROSOMAL SYSTEM, JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS 196: 213 (1976).","journal-title":"JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS"},{"key":"e_1_2_1_16_1","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/0003-9861(69)90303-8","volume":"134","year":"1969","unstructured":"MITOMA, C, NATURE OF EFFECT OF CAFFEINE ON DRUG-METABOLIZING ENZYMES, ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS 134: 434 (1969).","journal-title":"ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS"},{"key":"e_1_2_1_17_1","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1002\/cpt197824140","volume":"24","year":"1978","unstructured":"PARSONS, W.D., EFFECT OF SMOKING ON CAFFEINE CLEARANCE, CLINICAL PHARMACOLOGY & THERAPEUTICS 24: 40 (1978).","journal-title":"CLINICAL PHARMACOLOGY & THERAPEUTICS"},{"key":"e_1_2_1_18_1","first-page":"130","volume":"23","year":"1978","unstructured":"SOYKA, L.F., PERINATAL EXPOSURE TO METHYLXANTHINES - POSSIBLE EFFECTS ON PREGNANCY OUTCOME, CLINICAL PHARMACOLOGY & THERAPEUTICS 23: 130 (1978).","journal-title":"CLINICAL PHARMACOLOGY & THERAPEUTICS"},{"key":"e_1_2_1_19_1","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1542\/peds.36.3.367","volume":"36","year":"1965","unstructured":"STERN, L, ENVIRONMENTAL TEMPERATURE OXYGEN CONSUMPTION AND CATECHOLAMINE EXCRETION IN NEWBORN INFANTS, PEDIATRICS 36: 367 (1965).","journal-title":"PEDIATRICS"},{"key":"e_1_2_1_20_1","first-page":"185","volume":"13","year":"1976","unstructured":"SVED, S, HUMAN METABOLISM OF CAFFEINE TO THEOPHYLLINE, RESEARCH COMMUNICATIONS IN CHEMICAL PATHOLOGY AND PHARMACOLOGY 13: 185 (1976).","journal-title":"RESEARCH COMMUNICATIONS IN CHEMICAL PATHOLOGY AND PHARMACOLOGY"}],"container-title":["Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.science.org\/doi\/pdf\/10.1126\/science.515734","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,14]],"date-time":"2024-01-14T15:52:10Z","timestamp":1705247530000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.science.org\/doi\/10.1126\/science.515734"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1979,12,14]]},"references-count":20,"journal-issue":{"issue":"4424","published-print":{"date-parts":[[1979,12,14]]}},"alternative-id":["10.1126\/science.515734"],"URL":"https:\/\/doi.org\/10.1126\/science.515734","relation":{},"ISSN":["0036-8075","1095-9203"],"issn-type":[{"value":"0036-8075","type":"print"},{"value":"1095-9203","type":"electronic"}],"subject":[],"published":{"date-parts":[[1979,12,14]]}}}